Defactinib (hydrochloride) [1073160-26-5]
Referencia HY-12289A-5mg
embalaje : 5mg
Marca : MedChemExpress
| Descripciòn | IC50 & Target |
FAK[1] |
|---|---|
| In Vitro |
Defactinib (VS-6063) inhibits FAK phosphorylation at the Tyr397 site in a time- and dose-dependent manner. RPPA data shows that Defactinib reduces levels of AKT and YB-1 in taxane-resistant cell lines. The expression of pFAK (Tyr397) is statistically significantly inhibited by Defactinib in a dose-dependent manner in all cell lines. Defactinib inhibits pFAK (Tyr397) expression within 3 hours, with a gradual return of expression by 48 hours[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. |
Usted podría estar interesado también en los siguientes productos:
Referencia
Descripción
Cond.
Precio Sin IVA

